Provided by Tiger Fintech (Singapore) Pte. Ltd.

IX Biopharma

0.019
+0.0015.56%
Volume:475.60K
Turnover:9.04K
Market Cap:16.87M
PE:-1.60
High:0.019
Open:0.019
Low:0.019
Close:0.018
Loading ...

Company Profile

Company Name:
IX Biopharma
Exchange:
SGX
Establishment Date:
2004
Employees:
42
Office Location:
No. 14-01 Great World City East Lobby,1 Kim Seng Promenade,Singapore,Singapore
Zip Code:
237994
Fax:
65 6235 2170
Introduction:
IX Biopharma Ltd. is a Singapore-based specialty pharmaceutical and nutraceutical company. The Company is focused on the development, manufacturing and commercialization of innovative therapies for the treatment of acute and breakthrough pain, and other health conditions. It has developed a patented drug delivery platform technology, WaferiX. WaferiX is a novel multi-drug delivery platform comprising a highly porous, amorphous and non-ionic matrix in a solid dosage form. The Company operates through two segments: Specialty Pharmaceutical and Nutraceutical segments. Specialty Pharmaceutical primary business activities are the development, manufacturing and sale of pharmaceutical and medicinal cannabis products. Nutraceutical primary business activities are the sale of nutraceutical products. The Company's pipeline of products under development includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management.